Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein

Abstract

The present study indicated that naïve VHH library could be used as a potential resource for rapid acquisition and exploitation of antiviral nanobodies. Heterodimer nanobody Nb91-Nb3-hFc may serve as a potential therapeutic agent for the treatment of COVID-19.